Drug Search Results
More Filters [+]

ABOMEG-B-09

Alternative Names: abomeg-b-09, abomegb09, abomeg b 09
Latest Update: 2014-12-02
Latest Update Note: Clinical Trial Update

Product Description

ABO/MEG-B-09 syrup in children with acute cough (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01259674)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Aboca Spa Societa' Agricola
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ABOMEG-B-09

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ABOMEG

P3

Completed

Other

2011-04-01

Recent News Events

Date

Type

Title